We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$33.8B
AUM Growth
+$2.87B
Cap. Flow
+$1.54B
Cap. Flow %
4.54%
Top 10 Hldgs %
16.03%
Holding
1,494
New
35
Increased
872
Reduced
242
Closed
39

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$273M
2
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$151M
3
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$131M
4
DD icon
DuPont de Nemours
DD
+$103M
5
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$59.3M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$254M
2
DD
Du Pont De Nemours E I
DD
+$89.3M
3
RAI
Reynolds American Inc
RAI
+$76.3M
4
MRK icon
Merck
MRK
+$41.1M
5
CHTR icon
Charter Communications
CHTR
+$34.1M

Sector Composition

Rank Sector Weight
1 Financials 17.53%
2 Technology 16.04%
3 Healthcare 13.34%
4 Industrials 10.24%
5 Communication Services 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTPH
1401
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$192K ﹤0.01%
1,400
– –
COLL icon
1402
Collegium Pharmaceutical
COLL
$834M
$189K ﹤0.01%
18,000
– –
CMRX
1403
DELISTED
Chimerix, Inc.
CMRX
$178K ﹤0.01%
34,000
– –
STML
1404
DELISTED
Stemline Therapeutics, Inc.
STML
$178K ﹤0.01%
16,000
– –
PETX
1405
DELISTED
Aratana Therapeutics, Inc.
PETX
$178K ﹤0.01%
29,000
– –
ACGN
1406
DELISTED
Aceragen Inc
ACGN
$176K ﹤0.01%
581
– –
LUMO
1407
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$173K ﹤0.01%
1,889
– –
DRRX
1408
DELISTED
DURECT Corp
DRRX
$172K ﹤0.01%
9,700
– –
TFSL icon
1409
TFS Financial
TFSL
$4.89B
$169K ﹤0.01%
10,467
– –
INSY
1410
DELISTED
Insys Therapeutics, Inc.
INSY
$169K ﹤0.01%
19,000
– –
MNOV icon
1411
MediciNova
MNOV
$65.5M
$166K ﹤0.01%
26,000
– –
CORI
1412
DELISTED
Corium International, Inc.
CORI
$166K ﹤0.01%
15,000
– –
KURA icon
1413
Kura Oncology
KURA
$882M
$164K ﹤0.01%
11,000
– –
LCTX icon
1414
Lineage Cell Therapeutics
LCTX
$278M
$162K ﹤0.01%
65,151
– –
PDSB icon
1415
PDS Biotechnology
PDSB
$13.5M
$161K ﹤0.01%
750
– –
VIVS
1416
VivoSim Labs
VIVS
$1.16M
$159K ﹤0.01%
313
– –
MACK
1417
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$157K ﹤0.01%
13,726
-1
-0% -$11
ATHX
1418
DELISTED
Athersys, Inc. Common Stock
ATHX
$154K ﹤0.01%
3,000
– –
PVLA
1419
Palvella Therapeutics
PVLA
$2.23B
$150K ﹤0.01%
325
– –
VCYT icon
1420
Veracyte
VCYT
$3.59B
$149K ﹤0.01%
17,000
– –
CCXI
1421
DELISTED
ChemoCentryx, Inc.
CCXI
$141K ﹤0.01%
19,000
– –
ARDX icon
1422
Ardelyx
ARDX
$1.03B
$140K ﹤0.01%
25,000
– –
SIOX
1423
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$138K ﹤0.01%
2,500
– –
NERV icon
1424
Minerva Neurosciences
NERV
$187M
$137K ﹤0.01%
2,250
– –
CPRX
1425
DELISTED
Catalyst Pharmaceutical
CPRX
$136K ﹤0.01%
54,000
– –
55 56
57
58 59

Similar funds

WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

State of Wisconsin Investment Board's Q3 2017 Portfolio in Review

As of Q3 2017, State of Wisconsin Investment Board held 1,494 positions worth $33.8B, up 9.2% from $31B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

State of Wisconsin Investment Board deployed $1.54B of net new capital in Q3 2017, opening 35 new positions and adding to 872 existing holdings. Its largest new stake was Discovery, Inc. Series C Common Stock: 6,728,154 shares worth $136M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $254M trimmed.

  • State of Wisconsin Investment Board's largest Q3 2017 buy was Discovery, Inc. Series C Common Stock: 6,728,154 shares worth $136M.
  • State of Wisconsin Investment Board added most to Alphabet (Google) Class A in Q3 2017, an estimated $273M increase.
  • State of Wisconsin Investment Board's biggest Q3 2017 reduction was Alphabet (Google) Class C, cutting an estimated $254M.
  • State of Wisconsin Investment Board fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $89.3M.
  • State of Wisconsin Investment Board's ten largest holdings make up 16% of its $33.8B portfolio in Q3 2017.
  • State of Wisconsin Investment Board opened 35 new positions and closed 39 in Q3 2017.
  • State of Wisconsin Investment Board's portfolio value rose 9.2% quarter-over-quarter to $33.8B.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2017, filed 1 Nov 2017.